Cargando…

Parkinsonian Symptoms, Not Dyskinesia, Negatively Affect Active Life Participation of Dyskinetic Patients with Parkinson’s Disease

BACKGROUND: The impact of slight-to-moderate levodopa-induced dyskinesia (LID) on the level of participation in active life in patients with Parkinson’s disease (PD) has never been objectively determined. METHODS: Levels of LID, tremor and bradykinesia were measured during best-ON state in 121 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goubault, Etienne, Bogard, Sarah, Blanchet, Pierre J., Bézard, Erwan, Vincent, Claude, Martino, Davide, Sarna, Justyna, Monchi, Oury, Duval, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394214/ https://www.ncbi.nlm.nih.gov/pubmed/32775034 http://dx.doi.org/10.5334/tohm.403

Ejemplares similares

Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living
por: Goubault, Etienne, et al.
Publicado: (2019)

Cardinal Motor Features of Parkinson’s Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia
por: Goubault, Etienne, et al.
Publicado: (2018)

Can We Predict the Motor Performance of Patients With Parkinson's Disease Based on Their Symptomatology?
por: Lebel, Karina, et al.
Publicado: (2020)

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats
por: Fletcher, Edward J. R., et al.
Publicado: (2020)

Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
por: Haberfehlner, Helga, et al.
Publicado: (2019)

Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
por: Lang, Stefan, et al.
Publicado: (2020)

Auto detection and segmentation of daily living activities during a Timed Up and Go task in people with Parkinson’s disease using multiple inertial sensors
por: Nguyen, Hung, et al.
Publicado: (2017)

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
por: Aboulghasemi, Nazanin, et al.
Publicado: (2018)

Parkinsonian Patients and Poor Awareness of Dyskinesias
por: Pietracupa, Sara, et al.
Publicado: (2014)

Basal Ganglia Circuits Underlying the Pathophysiology of Levodopa-Induced Dyskinesia
por: Barroso-Chinea, Pedro, et al.
Publicado: (2010)

Theta-Burst Stimulation for Cognitive Enhancement in Parkinson's Disease With Mild Cognitive Impairment: A Randomized, Double-Blind, Sham-Controlled Trial
por: Lang, Stefan, et al.
Publicado: (2020)

Association Between BDNF Val66Met Polymorphism and Mild Behavioral Impairment in Patients With Parkinson's Disease
por: Ramezani, Mehrafarin, et al.
Publicado: (2021)

Do Bradykinesia and Tremor Interfere in Voluntary Movement of Essential Tremor Patients? Preliminary Findings
por: Goubault, Etienne, et al.
Publicado: (2017)

Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity
por: Lang, Stefan, et al.
Publicado: (2020)

Patterns of brain activity during a set-shifting task linked to mild behavioral impairment in Parkinson’s disease
por: Jin Yoon, Eun, et al.
Publicado: (2021)

Dopamine D1 receptor signalling in dyskinetic Parkinsonian rats revealed by fiber photometry using FRET-based biosensors
por: Jones-Tabah, Jace, et al.
Publicado: (2020)

Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learning
por: Ramezani, Mehrafarin, et al.
Publicado: (2021)

Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
por: Shi, Ziqing, et al.
Publicado: (2020)

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016)

Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience
por: de Rus Jacquet, Aurelie, et al.
Publicado: (2021)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)

IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
por: Aron Badin, Romina, et al.
Publicado: (2013)

The selective 5-HT(1A) receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets
por: Fisher, Ria, et al.
Publicado: (2020)

Probable REM sleep behavior disorder is associated with longitudinal cortical thinning in Parkinson’s disease
por: Yoon, Eun Jin, et al.
Publicado: (2021)

Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and L-Dopa induced dyskinesia
por: Malave, Lauren, et al.
Publicado: (2021)

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
por: Aron Badin, Romina, et al.
Publicado: (2013)

Neuroimaging studies of striatum in cognition part II: Parkinson's disease
por: Hanganu, Alexandru, et al.
Publicado: (2015)

Subthalamic Single Cell and Oscillatory Neural Dynamics of a Dyskinetic Medicated Patient With Parkinson's Disease
por: Ozturk, Musa, et al.
Publicado: (2020)

Differential Effects of Dopaminergic Therapies on Dorsal and Ventral Striatum in Parkinson's Disease: Implications for Cognitive Function
por: MacDonald, Penny A., et al.
Publicado: (2011)

RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson’s disease
por: Eshraghi, Mehdi, et al.
Publicado: (2020)

7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate
por: Herrero, M. T., et al.
Publicado: (2023)

L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
por: Porras, Gregory, et al.
Publicado: (2014)

Involvement of Autophagy in Levodopa‐Induced Dyskinesia
por: Feyder, Michael, et al.
Publicado: (2021)

Basal ganglia neuropeptides show abnormal processing associated with L-DOPA-induced dyskinesia
por: Hulme, Heather, et al.
Publicado: (2022)

Early infantile epileptic-dyskinetic encephalopathy due to biallelic PIGP mutations
por: Vetro, Annalisa, et al.
Publicado: (2020)

Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
por: Bastide, Matthieu F., et al.
Publicado: (2017)

Neuroradiological and Neurophysiological Characteristics of Patients With Dyskinetic Cerebral Palsy
por: Park, Byung-Hyun, et al.
Publicado: (2014)

Rare Form of Dyskinetic Movements Associated with Alcohol Withdrawal
por: Prakash, Sathya, et al.
Publicado: (2016)

Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
por: Santini, Emanuela, et al.
Publicado: (2010)

Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with 6-Month Followup
por: Frazzitta, Giuseppe, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s1h2igvtcv7o88ni9b6tqqdsi0